BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 29, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Aug. 3, 2015
View Archived Issues
Inside the Beltway: BPC says 'pragmatic' studies plus RCTs needed for premarket applications
Read More
Heartware Lifted by rival buyout: Heartware sees a 5% increase in revenue; pumped by St. Jude/Thoratec merger
Read More
Financings: Nanosphere adds amendment to $30 million term loan
Read More
Hit Bits: Calgary gains MFDS certification in Korea for ResolutionMD
Read More
MDD's Winners and Losers
Read More
MDD's Company Stock Report
Read More
MDD's Neurology Extra
Read More
Company prospects inflated by approval: FDA approval of dual balloon system could Reshape weight loss options
The market for weight loss devices has seen a flurry of recent activity, most recently with the FDA approval of an intragastric dual balloon system from Reshape Medical (San Clemente, Calif.).
Read More
Shares' Value Slimming down: GI Dynamics sees stock plunge; plans to re-evaluate after ENDO trial ends
Read More
